Skip to content

Clinical trials

Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: Spain Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20151
20161
20183
20193
20202
20211
20222
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting4
Terminated4
Completed3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Princess Maxima Center for Pediatric Oncology3
Celgene2
Novartis Pharmaceuticals2
AbbVie1
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Gamida Cell ltd1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma19
Leukemia8
Leukemia, Myeloid, Acute7
Recurrence6
Burkitt Lymphoma3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3
Hematologic Neoplasms2
Leukemia, Biphenotypic, Acute2
Lymphoma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.